Ticagrelor labels and packages: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Labels & Packages== '''PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – 90 mg''' NDC -0186-0777-60 60 tablets BRILINTA™ tica...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Ticagrelor#Package and Label Display Panel]]
{{Ticagrelor}}
{{CMG}}; {{AE}} {{JH}}
 
==Labels & Packages==
 
'''PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – 90 mg'''
 
NDC -0186-0777-60
 
60 tablets
 
BRILINTA™
 
ticagrelor tablets
 
90 mg
 
Rx only
 
Dispense the accompanying Medication Guide to each patient.
 
AstraZeneca
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BRILINTA (TICAGRELOR) TABLET [ASTRAZENECA LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7b3f443-e83d-4bf2-0e96-023448fed9a8 | publisher =  | date =  | accessdate = 26 February 2014 }}</ref>
 
{|
|[[File:Ticagrelor_15.png|thumb|800px]]
|}
 
{|
|[[File:Ticagrelor_16.png|thumb|800px]]
|}
 
{|
|[[File:Ticagrelor_17.png|thumb|800px]]
|}
 
==References==
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BRILINTA (TICAGRELOR) TABLET [ASTRAZENECA LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7b3f443-e83d-4bf2-0e96-023448fed9a8 | publisher =  | date =  | accessdate = 26 February 2014 }}</ref>
{{Reflist|2}}
 
{{Antithrombotics}}
 
[[Category:ADP receptor inhibitors]]
[[Category:Triazolopyrimidines]]
[[Category:Organofluorides]]
[[Category:Alcohols]]
[[Category:AstraZeneca]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 02:27, 22 July 2014